Omega Healthcare Investors (NYSE:OHI) Releases FY 2024 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 2.840-2.860 for the period, compared to the consensus EPS estimate of 2.830. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

OHI has been the subject of several analyst reports. Scotiabank increased their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. Truist Financial increased their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. BNP Paribas upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price for the company in a report on Thursday. Finally, BMO Capital Markets boosted their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a report on Monday, October 7th. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $39.70.

Omega Healthcare Investors Stock Performance

Shares of Omega Healthcare Investors stock traded down $1.27 on Friday, reaching $41.20. 1,901,157 shares of the company traded hands, compared to its average volume of 1,648,304. The company has a debt-to-equity ratio of 1.19, a current ratio of 5.79 and a quick ratio of 5.79. The firm has a market capitalization of $10.62 billion, a PE ratio of 30.28, a PEG ratio of 1.37 and a beta of 1.00. The company has a 50 day moving average of $40.47 and a 200 day moving average of $35.96. Omega Healthcare Investors has a 52 week low of $27.53 and a 52 week high of $44.42.

Omega Healthcare Investors (NYSE:OHI) last released its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 9.19% and a net margin of 34.41%. The firm had revenue of $252.70 million during the quarter, compared to analysts’ expectations of $205.92 million. During the same period in the prior year, the business earned $0.74 earnings per share. The business’s quarterly revenue was up 17.5% compared to the same quarter last year. Equities analysts forecast that Omega Healthcare Investors will post 2.69 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be issued a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.50%. The ex-dividend date of this dividend is Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 197.06%.

Insider Activity at Omega Healthcare Investors

In other news, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by company insiders.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.